Ivabradine in patients with heart failure: a systematic literature review by Zeba M. Khan, Jean Baptiste Briere, Elzbieta Olewinska, Fatma Khrouf, Mateusz Nikodem

Connect to this object online.

Real-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UK by Kevin Bowrin, Jean-Baptiste Briere, Pierre Levy, Aurélie Millier, Jean Tardu, Mondher Toumi

Connect to this object online.

Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review by Rupert Bauersachs, Uwe Zeymer, Jean-Baptiste Brière, Caroline Marre, Kevin Bowrin, Maria Huelsebeck

Connect to this object online.

Estimation of the costs attributable to vitamin K antagonist treatment in patients with non-valvular atrial fibrillation from a French societal perspective by Pierre Levy, David M. Smadja, Julie Dorey, Mondher Toumi, Anna-Katharina Meinecke, Kevin Bowrin, Jean-Baptiste Briere

Connect to this object online.

Antithrombotic Treatments in Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomised Controlled Trials by Rupert Bauersachs, Olivia Wu, Jean-Baptiste Briere, Kevin Bowrin, Katarzyna Borkowska, Anna Jakubowska, Vanessa Taieb, Mondher Toumi, Maria Huelsebeck

Connect to this object online.

Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibril... by Craig I. Coleman, Jean-Baptiste Briere, Laurent Fauchier, Pierre Levy, Kevin Bowrin, Mondher Toumi, Aurélie Millier, Vanessa Taieb, Olivia Wu

Connect to this object online.